Gross cystic disease fluid protein-15

From Libre Pathology
Revision as of 12:34, 15 January 2014 by Michael (talk | contribs)
Jump to navigation Jump to search

Gross cystic disease fluid protein-15, usually abbreviated GCDFP-15 and sometimes GCDFP, is an immunostain help used to identify breast carcinoma.

It is also known as BRST-2.[1]

It is much less sensitive than mammoglobin.[2]

Microscopic

Features:

  • Cytoplasmic staining.

Images

www:

See also

References

  1. ↑ Fiel, MI.; Cernaianu, G.; Burstein, DE.; Batheja, N.. "Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens.". Acta Cytol 40 (4): 637-41. PMID 8693878.
  2. ↑ Bhargava, R.; Beriwal, S.; Dabbs, DJ. (Jan 2007). "Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity.". Am J Clin Pathol 127 (1): 103-13. doi:10.1309/TDP92PQLDE2HLEET. PMID 17145637.
  3. ↑ URL: http://www.ptglab.com/PView/PIP,GCDFP-15-Antibody-16068-1-AP-PVIEW.htm. Accessed on: 3 January 2014.
Retrieved from "https://librepathology.org/w/index.php?title=Gross_cystic_disease_fluid_protein-15&oldid=27932"